Add Yahoo as a preferred source to see more of our stories on Google. Syringes are seen in front of a displayed Biontech logo in this illustration (Reuters) - BioNtech has dosed the first patient with ...

When Lauren went to her doctors with stinging clusters of sores on her genitals, she assumed the pain was from a urinary tract infection. But at the OB-GYN, her doctor swabbed the bumps and told her ...

SARASOTA, Fla., Aug. 31, 2017 /PRNewswire/ -- Many websites provide basic information on genital herpes. However, most often, these websites overlook issues of great importance to many genital herpes ...

A major UK clinical trial has shown that adding the corticosteroid dexamethasone to standard antiviral treatment for ...

A major UK clinical trial has shown that adding the corticosteroid dexamethasone to standard antiviral treatment for encephalitis (brain inflammation), caused by herpes simplex virus (HSV) does not ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Patients with inflammatory bowel disease had a higher incidence of herpes zoster than the general ...

Herpes Cure Advocacy is a non-profit, grassroots, membership-based advocacy organization w/a goal of treatment, cure + prevention for HSV-1 + 2. The National Institutes of Health (NIH) has assembled a ...

Vaccination rates for pneumococcal and herpes zoster vaccines are often suboptimal in veterans with chronic inflammatory diseases who are taking biologic medications. Targeted quality improvement ...

Pritelivir demonstrated clinically meaningful and highly statistically significant superiority (p=0.0047) in lesion healing up to 28 days of treatment, compared with standard-of-care (SoC) treatments ...

Scientists may be able to turn a longtime germ foe into a cancer-fighting ally, new research this week suggests. In preliminary data from a Phase I trial, a genetically modified version of the herpes ...

Dec 21 (Reuters) - BioNtech 22UAy.DE has dosed the first patient with its BNT163 herpes vaccine candidate designed to prevent genital lesions as part of a first-in-human Phase 1 clinical research ...